Clinical and immunological differences between early and late-onset myasthenia gravis in Japan
Authors:
- Kimiaki UtsugisawaKUKimiaki Utsugisawa
- Yuriko NaganeYNYuriko Nagane
- Takashi SatohTSTakashi Satoh
- Masataka KuwanaMKMasataka Kuwana
- Norihiro SuzukiNSNorihiro Suzuki
- 1 January 2011
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 230 (1-2) , 148-152
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increasing incidence of elderly onset patients with myasthenia gravis in a local area of JapanJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- Myasthenia Gravis in the ElderlyAnnals of the New York Academy of Sciences, 2008
- Classification of Myasthenia Gravis Based on Autoantibody StatusArchives of Neurology, 2007
- Clinical and serological study of myasthenia gravis in HuBei Province, ChinaJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Striational Antibodies in Myasthenia GravisArchives of Neurology, 2005
- HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndromeJournal of Neuroimmunology, 2005
- A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in JapanClinical Immunology, 2004
- Thymoma in patients with MGNeurology, 2002
- HLA antigens in Japanese patients with myasthenia gravis.Journal of Clinical Investigation, 1990